Home NDC 49702-238 NDC 49702-238 - Cabenuva This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 49702-238
Package NDCs from labels 49702-238-01, 49702-238-64, 49702-238-03, 49702-238-61
Manufacturer ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV
Effective date 2025-11-26
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 49702-238-01 Cabenuva 3 mL in 1 VIAL INJECTION, SUSPENSION, EXTENDED 1 mL 200 mg in 1mL 16 49702-238-64 Cabenuva 3 mL in 1 VIAL INJECTION, SUSPENSION, EXTENDED 1 mL 200 mg in 1mL 16 49702-238-03 Apretude 3 mL in 1 VIAL INJECTION, SUSPENSION, EXTENDED 3 mL 200 mg in 1mL 8 49702-238-61 Apretude 3 mL in 1 VIAL INJECTION, SUSPENSION, EXTENDED 3 mL 200 mg in 1mL 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 49702-238 CABENUVA (CABOTEGRAVIR AND RILPIVIRINE) KIT [VIIV HEALTHCARE COMPANY] 14 Unmatched 20250416_1698baf3-f895-4c42-a1b1-e9ee3f20da36.zip 49702-238 APRETUDE (CABOTEGRAVIR) KIT [VIIV HEALTHCARE COMPANY] 8 Unmatched 20250419_4338428e-43d4-4e02-ac9d-bd98e738a7da.zip